Search

Author/Creator Yardley, Denise

1. Correlation between work productivity loss and EORTC QLQ-C30 and -BR23 domains from the MONALEESA-7 trial of premenopausal women with HR+/HER2− advanced breast cancer. (February 2022)

Authors:
Tripathy, Debu; Curteis, Tristan; Hurvitz, Sara; Yardley, Denise; Franke, Fabio; Babu, K. Govind; Wheatley-Price, Paul; Im, Young-Hyuck; Pencheva, Radost; Eddowes, Lucy A.; Dionne, Pierre-Alexandre; Chandiwana, David; Pathak, Purnima; Lanoue, Brad; Harbeck, Nadia
Journal:
Therapeutic advances in medical oncology
Issue:
Volume 14(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Erratum to: 'Phase II/III weekly nab-paclitaxel plus gemcitabine or carboplatin versus gemcitabine/carboplatin as first-line treatment of patients with metastatic triple-negative breast cancer (the tnAcity study): study protocol for a randomized controlled trial. Issue 1 (December 2016)

Authors:
Yardley, Denise; Brufsky, Adam; Coleman, Robert; Conte, Pierfranco; Cortes, Javier; Glück, Stefan; Nabholtz, Jean-Mark; O'Shaughnessy, Joyce; Beck, Robert; Ko, Amy; Renschler, Markus; Barton, Debora; Harbeck, Nadia
Journal:
Trials
Issue:
Volume 17:Issue 1(2016)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. First‐Line Treatment Patterns and Clinical Outcomes in Patients With HER2‐Positive and Hormone Receptor‐Positive Metastatic Breast Cancer From registHER. (7th May 2013)

Authors:
Tripathy, Debu; Kaufman, Peter A.; Brufsky, Adam M.; Mayer, Musa; Yood, Marianne Ulcickas; Yoo, Bongin; Quah, Cheng; Yardley, Denise; Rugo, Hope S.
Journal:
Oncologist
Issue:
Volume 18:Number 5(2013)
Page Start:
501
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. HERMIONE: a randomized Phase 2 trial of MM-302 plus trastuzumab versus chemotherapy of physician's choice plus trastuzumab in patients with previously treated, anthracycline-naïve, HER2-positive, locally advanced/metastatic breast cancer. Issue 1 (December 2016)

Authors:
Miller, Kathy; Cortes, Javier; Hurvitz, Sara; Krop, Ian; Tripathy, Debu; Verma, Sunil; Riahi, Kaveh; Reynolds, Joseph; Wickham, Thomas; Molnar, Istvan; Yardley, Denise
Journal:
BMC cancer
Issue:
Volume 16:Issue 1(2016)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Phase II/III weekly nab-paclitaxel plus gemcitabine or carboplatin versus gemcitabine/carboplatin as first-line treatment of patients with metastatic triple-negative breast cancer (the tnAcity study): study protocol for a randomized controlled trial. Issue 1 (December 2015)

Authors:
Yardley, Denise; Brufsky, Adam; Coleman, Robert; Conte, Pierfranco; Cortes, Javier; Glück, Stefan; Nabholtz, Jean-Mark; O'Shaughnessy, Joyce; Beck, Robert; Ko, Amy; Renschler, Markus; Barton, Debora; Harbeck, Nadia
Journal:
Trials
Issue:
Volume 16:Issue 1(2015)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Quantitative measurement of HER2 expression in breast cancers: comparison with 'real-world' routine HER2 testing in a multicenter Collaborative Biomarker Study and correlation with overall survival. Issue 1 (December 2015)

Authors:
Yardley, Denise; Kaufman, Peter; Huang, Weidong; Krekow, Lea; Savin, Michael; Lawler, William; Zrada, Stephen; Starr, Alexander; Einhorn, Harvey; Schwartzberg, Lee; Adams, John; Lie, Yolanda; Paquet, Agnes; Sperinde, Jeff; Haddad, Mojgan; Anderson, Steve; Brigino, Marlon; Pesano, Rick; Bates, Mic...
Journal:
Breast cancer research
Issue:
Volume 17:Issue 1(2015)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗